A PYMNTS Company

U.S./China: Chinese company to buy US DNA sequencing firm

By  |  September 21, 2012

Complete Genomics, a struggling DNA sequencing company in Silicon Valley, said on Monday that it had agreed to be acquired for USD 117.6 million by BGI-Shenzhen, a Chinese company that operates the world’s largest sequencing operation. The deal will need antitrust clearance, because of two key players in the DNA sequencing business in a highly capital intensive and research intensive industry, as well as clearance from a national security review by the Committee on Foreign Investment in the United States. It also requires approval from certain governmental authorities in China.

Full Content: DealBock

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.